Extended PPI use not associated with cognitive decline — 4 insights

Written by Eric Oliver | February 15, 2018 | Print  |

Prolonged proton pump inhibitor use did not cause cognitive decline in middle-aged and older individuals, according to two studies from Denmark, Medpage Today reports.

Here's what you should know:

1. Study researchers examined 2,346 middle-aged individuals (median age of 57 years) over 10 years and 2,475 older individuals (median age of 75 years) over two years. In both instances researchers failed to find a statistically significant effect of long-term PPI exposure on cognitive function.

2. Researchers said they saw no instances of cognitive decline when comparing baseline scores to follow-up scores.

3. Researchers concluded the results were in line with another study that showed there was no link between PPI use and mild cognitive impairment.

4. Researchers did note their 2-year follow-up time could've been too short to recognize any long-term cognitive decline.

More articles on gastroenterology:
Maine physician: Halting physician-aimed opioid marketing now is '20 years' too late
Somnia Anesthesia shakes up leadership team with new appointments — 3 insights
Survey says medical students learn the most about perioperative medicine by pairing anesthesiology with general surgery rotation

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.